CREATING BUDGETS - THE BASICS
|
|
- Imogene Clark
- 6 years ago
- Views:
Transcription
1 CREATING BUDGETS - THE BASICS
2 AGENDA REVIEW OF STUDY PROTOCOL AND DESIGN REVIEW OF STUDY SCHEMA DEVELOPMENT OF STUDY BUDGET BUDGET NEGOTIATION BUDGET MANAGEMENT REIMBURSEMENT
3 Review of Study Protocol and Design Protocol Review Department Review IRB Review Develop and Negotiate Budget Contract Review and Negotiation Finalize: Budget Contract IRB
4 STUDY SCHEMA STUDY-REQUIRED LABORATORY TESTS STUDY-REQUIRED PROCEDURES STUDY DRUG ADMINISTRATION AND SCHEDULE; RESEARCH PHARMACY STUDY-SPECIFIC ELEMENTS AFFECTING MANPOWER LOCATION WHERE RESEARCH WILL OCCUR REVIEW PROTOCOL FOR ITEMS NOT IN SCHEMA
5 BUDGET DEVELOPMENT and NEGOTIATION
6 WHAT IS A BUDGET? BUDGET : n 1. Total amount of money allocated for a certain purpose. 2. The estimated cost of living, operating, etc. -vt 1. To put on a budget.
7 ANALYZE THE PROTOCOL LABORATORY TESTS PROCEDURES STUDY DRUG PHARMACY NEEDS RESEARCH NURSING DATA MANAGEMENT ADMINISTRATIVE EFFORT PRINCIPAL INVESTIGATOR SUPPLIES DATA STORAGE PROCEDURES MANPOWER LABS STUDY BUDGET STUDY DRUG PHARMACY OTHER COSTS
8 IDENTIFY STUDY COSTS Key Personnel Lab Costs Procedure Costs Pharmacy Costs Indirect Costs Miscellaneous Costs
9 IDENTIFY KEY PERSONNEL COSTS PRINCIPAL INVESTIGATOR (P.I.) STUDY COORDINATOR DATA MANAGER PHARMACIST ADMINISTRATIVE CLERICAL FINANCIAL NURSE MANAGER REGULATORY
10 PRINCIPAL INVESTIGATOR EVALUATE EFFORT INVOLVEMENT PER PATIENT PER VISIT PER TREATMENT CYCLE CONSIDER EXTENDED TIME FOR RESEARCH TELECONFERENCES CRFs MONITOR VISITS
11 ESTIMATING HOURS FOR STUDY COORDINATION STUDY INITIATION > ARCHIVING STUDY INITIATION PROCESSES: ON-SITE VISIT, INSERVICE OF STAFF, AREAs SCREENING/RECRUITMENT PATIENT CARE: ENROLLMENT, PATIENT EDUCATION, TREATMENT, FOLLOW UP, TOXICITY REPORTING, QOL, DIARIES ADMINISTRATIVE: IRB, FDA, SPECIAL AREAS, MONITORS TELEPHONE, FAX, COMPUTER TIME REQUIRED HOSPITAL ROUNDS, STUDY VISITS CRF COMPLETION, QUERY RESOLUTION BILLING COMPLIANCE
12 ESTIMATING HOURS FOR DATA MANAGEMENT STUDY INITIATION > ARCHIVING STUDY INITIATION PROCESSES PATIENT CARE DOCUMENTATION: ENROLLMENT, PATIENT EDUCATION, TREATMENT, FOLLOW UP, TOXICITY REPORTING, QOL, DIARIES ADMINISTRATIVE: IRB, FDA, SPECIAL AREAS, MONITORS TELEPHONE, FAX, COPIER, COMPUTER TIME REQUIRED RADIOGRAPHIC REVIEWS RADIOLOGY, CARDIOLOGY, ETC. CRF COMPLETION, QUERY RESOLUTION STUDY ARCHIVAL
13 PHARMACY COSTS BRING in RESEARCH PHARMACIST: REVIEW and DISCUSSION of PROTOCOL DRUG ACCOUNTABILITY and STORAGE DRUG PREPARATION: MIXING, LABELING DRUG DISPENSING (INCLUDING PATIENT ED.) DELIVERY to HOSPITAL or CLINIC KNOWLEDGE of DRUG TOXICITIES/INTERACTIONS DRUG ORDERING, TRACKING EXPIRATION DATES DRUG RETURNS or DESTRUCTION at END of STUDY ADMINISTRATIVE: IRB, FDA, MONITORS, STAFF
14 LABORATORY AND PROCEDURE COSTS IDENTIFY LOCAL POLICIES and GUIDELINES --- LOCAL REVIEW --- LABS, PROCEDURES billed by Providers COSTS are TIME-SENSITIVE --- BUDGET for INCREASES ANCILLARY AREAS --- CONTACT DIRECTLY --- SPECIAL FEES --- RESEARCH ONLY SERVICES
15 PATIENT STIPENDS DETERMINED BY PROTOCOL REQUIREMENTS INVASIVE PROCEDURES TIME CONSUMING PROCEDURES EXTRA OFFICE VISITS TRAVEL TIME, PARKING PHARMACEUTICAL COMPANY or IRB INPUT
16 MISCELLANEOUS COSTS INDIRECT COSTS LOCAL IRB, CENTRAL IRB, SPECIAL RESEARCH AREAS SCREENING and RECRUITMENT, ADVERTISEMENT STORAGE (DRUG, SAMPLES, DATA) MEDICAL RECORDS MACHINE USE (COPIER, FAX, COMPUTERS, FREEZERS) SOCIAL SERVICES SUPPLIES (OFFICE, MEDICAL) ELECTRONIC DATA CAPTURE SHIPMENTS (OVERNIGHT COURIERS)
17 REMINDERS MAKE SURE THE PROTOCOL IS FINAL DATE THE BUDGET; LINK TO PROTOCOL VERSION and DATE MARK BUDGET VERSIONS ALLOW FOR ANNUAL INCREMENTAL INCREASES ENSURE SCREEN FAILURES ADDRESSED CANCELLATION FEES STUDY MONITOR VISITS/ON-CALL PAY INTERNAL START-UP MEETINGS PROTOCOL AMENDMENTS; IF COSTS, CONTACT SPONSOR to NEGOTIATE AMENDED CONTRACT BUDGET POST STUDY (QUERIES, NOTIFYING PATIENTS, FDA, ETC.)
18 ASK THE SPONSOR WILL A CENTRAL LAB BE USED? --- WILL SAMPLING SUPPLIES, SHIPPING/HANDLING MATERIALS, PRE-PAID AIRBILL BE PROVIDED? WILL THERE BE ANY OTHER CENTRAL REVIEWS? --- RADIOLOGY, NUCLEAR MEDICINE, CARDIOLOGY, ETC.? REQUEST APPLICABLE STUDY MANUALS TIMING OF MONITORING VISITS, STUDY PAYMENTS STUDY PAYMENTS VIA INVOICE --- CONSIDER AN INVOICE or ADMINISTRATIVE FEE DIRECT PAYMENT TO IRBs
19 BUDGET PREPARATION METHOD ELECTRONIC SYSTEM EXCEL SPREADSHEET WORD PROCESSOR *OBSOLETE PEN/PAPER *OBSOLETE TYPES SUMMARIZED DETAILED EXAMPLE FOLLOWS
20
21
22 REVIEW THE BUDGET WITH P.I. AND KEY PERSONNEL (CLINICAL and FINANCIAL) P.I./COORD DESIGNATES ITEMS THAT ARE STANDARD CARE (BILLED TO & REIMBURSED by THIRD PARTY PAYORS) WHEN IN DOUBT ABOUT THIRD PARTY BILLING, CHECK WITH LOCAL AREAS - COMPLIANCE OFFICE, PATIENT BILLING OFFICES, ETC.
23 FINALIZE THE BUDGET REVIEW ANY CHANGES WITH STAFF (PI, KEY PERSONNEL) REQUEST A NON-REFUNDABLE ADMINISTRATIVE START-UP FEE Separate from per patient budget or IRB fees OBTAIN APPROPRIATE INTERNAL APPROVALS SUBMIT TO SPONSOR FOR APPROVAL NEGOTIATE, NEGOTIATE, NEGOTIATE DATE BUDGET AND MARK WHEN FINAL
24 NON-REFUNDABLE ADMINSTRATIVE START-UP FEE CONSIDER THE FOLLOWING IN FEE ESTIMATION: CONFIDENTIALITY AGREEMENT PROCESS SPONSOR FEASIBILITY / SITE QUALIFICATION ATTENDANCE AT INVESTIGATOR MEETING INTERNAL REVIEWS INITIAL IRB SUBMISSION ACTIVITIES REGULATORY DOCUMENT MANAGEMENT COMPILATION, SUBMISSION TO SPONSOR, SET-UP FILES BUDGET DEVELOPMENT / NEGOTIATION INITIATION / START-UP MEETINGS
25 PAYMENT SCHEDULE NEGOTIATE ACCORDING TO THE FLOW OF THE PROTOCOL AND ESTIMATED FINANCIAL NEEDS % PER ENROLLED PATIENT % PER COMPLETED TREATMENT CYCLE % PER COMPLETED PATIENT (CHECK DEFINITION IN THE PROTOCOL and/or CONTRACT) AMOUNT PER CRF / VISIT ON A MONTHLY OR QUARTERLY BASIS
26 BUDGET MANAGEMENT SET UP STUDY ACCOUNT NUMBER IF THERE ARE MULTIPLE SOURCES OF SUPPORT FOR ONE STUDY, CONSIDER SEPARATE ACCOUNTS FOR EACH SOURCE OF SUPPORT STUDY EXPENSES CHARGED TO THE ACCOUNT NUMBER(S)
27 REIMBURSEMENT KNOW WHAT THE CLINICAL TRIAL CONTRACT SAYS TRACK/DOCUMENT: PATIENT SCREENING, PATIENT VISITS, MONITORING / CRF COLLECTION PER PATIENT PRO-ACTIVELY INVOICE THE SPONSOR UTILIZING DATA FROM ELECTRONIC MANAGEMENT SYSTEM SPREADSHEET DOCUMENTATION SPONSOR FORM OBTAIN SPONSOR APPROVAL FOR ONE-TIME or UNEXPECTED COSTS AND INVOICE AS THEY OCCUR DOCUMENT WHEN IT IS THE FINAL INVOICE
28 POST-STUDY BUDGET EVALUATION WAS THERE A BALANCE IN LABOR VS. REIMBURSEMENT? WHAT HIDDEN COSTS WERE COVERED or NOT COVERED? WERE MONITORING VISITS TOO LABOR INTENSIVE? WAS THE PAYMENT SCHEDULE EQUITABLE? IS THERE ROOM FOR IMPROVEMENT REGARDING COST OF DOING THE TRIAL AND THE BOTTOM LINE? IF YOU HAD TO DO IT OVER AGAIN, COULD YOU DO IT FOR THE SAME AMOUNT (AND NOT REQUIRE SUPPLEMENTAL RESOURCES TO COVER YOUR COSTS?)
29 BILLING COMPLIANCE REMINDER: IF THE SPONSOR IS PAYING FOR A SERVICE, DON T BILL THIRD PARTY PAYORS!
Making the Most of your Budget: Hidden Costs and Payment Terms
Making the Most of your Budget: Hidden Costs and Payment Terms Presented by Amanda Miller and Alex Opitz 2016 PharmaSeek Financial Services, LLC d.b.a. PFS Clinical, all rights reserved Presentation Overview
More informationEvaluation of a Protocol Budget
Evaluation of a Budget Margaret Matula, R.N., M.G.A. Director Research & Clinical Trials Anne Arundel Medical Center Annapolis, MD IPPCR 12/15/09 Slide # 1 Introduction Determine requirements: resources
More informationObjectives es To understand: Where the money comes from to pay the coordinator s salary Where the money comes from to pay for study procedures
Study Budget Development 2011 Putting a budget together.where do you start? t? Presented by Phyllis Klein, RN, CCRC, BSN Director, Regulatory, Compliance & Support Center for Clinical Studies Washington
More informationPREP Workshop #29 Building Clinical Trial Budgets. Presenter: Sumathy Sundarababu Ph.D Clinical Research Service
PREP Workshop #29 Building Clinical Trial Budgets Presenter: Sumathy Sundarababu Ph.D Clinical Research Service CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards
More informationStandard Operating Procedures. NETT Financial Plan
NETT Financial Plan Policy Overview: This policy describes the financial operations, considerations, and restrictions of the NETT. Policies and procedures outlined within include an overview of NETT funding
More informationBasics of Developing Study Budgets in Clinical Research
Basics of Developing Study Budgets in Clinical Research Office of Research Administration (ORA) Tatyana Vikhlyantseva, BS, CPCO, CCS-P, CPC Sr. Manager, Pre-Award Services Learning Objectives Recognize
More informationPresented by: Clinical Agreements Management Office of Sponsored Projects. Revised 12/04/17 PRN: 11/6/ :33 AM
Presented by: Clinical Agreements Management Office of Sponsored Projects Revised 12/04/17 PRN: 11/6/2018 10:33 AM Clinical Agreements Team: Contact Information Jeffrey Allen Director Jeffrey.Allen@yale.edu
More informationVersion Date 8/22/2013 UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE
UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE I. PURPOSE The purpose of these standard operating procedures is to outline
More informationTutorial Guide For ARIA Clinical Research Information Management System On LiNe
Tutorial Guide For ARIA Clinical Research Information Management System On LiNe LESSON 1 ARIA Web Site Pages 3-5 LESSON 2 Log-In Process Pages 6-8 LESSON 3 Profile Update Pages 9-11 LESSON 4 ARIA Saved
More informationOffice of Clinical Research
Office of Clinical Research Kimberlea Hauser, MBA Director Catherine Jahrsdorfer, RN, BSN Director of Clinical Services July 7/8, 2011 Today s Topics USF electronic Internal Form Clinical Research Contracts
More informationSponsorship Economics and Practicalities of Clinical Trials Budgeting and Building a Budget
Sponsorship Economics and Practicalities of Clinical Trials Budgeting and Building a Budget Udo Hoffmann, MD MPH Professor of Radiology, Harvard Medical School, Chief Cardiovascular Imaging, Department
More informationCLINICAL TRIAL AGREEMENT
PROTOCOL TITLE: PRODUCT: INSTITUTION: PRINCIPAL INVESTIGATOR: University of Connecticut Health Center CLINICAL TRIAL AGREEMENT THIS CLINICAL TRIAL AGREEMENT together with all Exhibits and Attachments,
More informationFinancing Clinical Trials Appropriate Compensa.on and Alloca.on of Study Budgets
Financing Clinical Trials Appropriate Compensa.on and Alloca.on of Study Budgets Audio Op)ons Host Built- in audio on your computer OR Separate audio dial- in: 914-614- 3429, Toll- Free: 866-952- 8437,
More informationWHAT EVERY NEW PRACTITIONER SHOULD CONSIDER
WHAT EVERY NEW PRACTITIONER SHOULD CONSIDER January 24, 2017 Andrew N. Meyercord Gray Reed & McGraw 1601 Elm Street Suite 4600 Dallas, Texas 75201 214.954.4135 ameyercord@grayreed.com 129 attorneys Full-service,
More informationPRESCRIPTION MONITORING PROGRAM MODEL ACT
Alliance of States with Prescription Monitoring Programs and National Association of State Controlled Substances Authorities Background information on the PRESCRIPTION MONITORING PROGRAM MODEL ACT October
More informationCapítulo 6 Managerial Accounting and Cost Concepts
Capítulo 6 Managerial Accounting and Concepts Exercise 1-1 (15 minutes) Object Direct 1. The wages of pediatric nurses The pediatric department 2. Prescription drugs A particular patient 3. Heating the
More informationRobert Howey, MBA, MHA, CPA Manager, Medicare Strategy Unit
Operational Management of Medicare Organ Acquisition Cost Centers The Prac;ce of Transplant Administra;on September 12, 2016 Robert Howey, MBA, MHA, CPA Manager, Medicare Strategy Unit 2016 MFMER slide-1
More informationALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP
Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Hungarian Company representative Office ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO
More informationInvestigator Site Landscape. Christine Pierre President x110
Investigator Site Landscape Christine Pierre President 410-696-5080 x110 Christine.pierre@myscrs.org SCRS Mission Unify the voice of the global clinical research site community for greater site sustainability.
More informationPLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: Date of birth: Sex: M F
TM RENFLEXIS for injection (inf liximab-abda)100 mg The Merck Access Program ENROLLMENT FORM Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning
More informationApplication date : 07/07/2014 Procedure for submitting a new clinical research project. Véronique Baudewyns
Page 1 / 10 Author Service de la Recherche Biomédicale Reviewer(s) Véronique Baudewyns Approved by Jean-Michel Hougardy Public All Investigators Study Nurse Study coordinator Paramedics Admin Staff Document
More informationBy Ricky Newton, CPA Director/Consultant Peninsula Cancer Institute T/A Cancer Specialists of Tidewater (757)
By Ricky Newton, CPA Director/Consultant Peninsula Cancer Institute T/A Cancer Specialists of Tidewater (757) 639-4855 Rnewton@tidewatercancer.com What all physicians need to know about Hospital/Physician
More informationPREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems. Office of Research Compliance. February 16 th, 2016
PREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems Office of Research Compliance February 16 th, 2016 1 CME Disclosure Statement The Northwell Health adheres to the ACCME
More informationPLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM
The Merck Access Program 2019 ENROLLMENT FORM Phone: 855-257-3932, Fax: 855-755-0518 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM AND FAX IT TO
More informationDifferences Between Industry-Sponsored, Industry-Supported and PI- Initiated Studies
Differences Between Industry-Sponsored, Industry-Supported and PI- Initiated Studies Frederick M. Frankhauser, JD, MBA, RPh Director, Grants and Contracts Tufts Medical Center Different Types of Agreements
More informationInvestigator Initiated Studies (IIS) Program Information Needed for Your Application
Dear Applicant: Thank you for your interest in Eisai s Investigator Initiated Studies (IIS) program. To assist you with preparing your IIS application, we have prepared a list of information that you should
More informationPatient Information. Financial Handbook For Liver Transplant Patients
Patient Information Financial Handbook For Liver Transplant Patients Beaumont Transplant Clinic Directory Beaumont Hospital, Royal Oak Medical Office Building 3535 West 13 Mile Road, Suite 644 Royal Oak,
More informationCOMMERCIAL RESEARCH POLICY
COMMERCIAL RESEARCH POLICY Document No R&I P01 Specific staff groups to whom this policy directly applies R&I department; Clinical researchers; Finance department Likely frequency of use Monthly Other
More information2019 Transition Policy
2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationPLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: _Date of birth: Sex: M F
The Merck Access Program ENROLLMENT FORM Phone: 855-257-3932, Fax: 855-755-0518, TTY: 855-257-7332 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM
More informationHEALTH CARE IN THE U.S.
HEALTH CARE IN THE U.S. Health Care in America! The U.S. government does not pay any part of the medical expenses for international students studying here.! The average cost of a visit to an urgent care
More informationFacilities and Administrative Cost
Georgia Regents University Policy Library Facilities and Administrative Cost Policy Owner: Sponsored Program Administration POLICY STATEMENT This policy establishes the principles for the appropriate allowable
More informationCost Reporting 101: Your Medicare Cost Report from A - M
Cost Reporting 101: Your Medicare Cost Report from A - M Paul Traczek, CPA, Partner Holly Pokrandt, CPA, Partner September 27, 2018 Cost Reporting 101: A Crash Course in the Basics What will be covered
More informationContents General Information General Information
Contents General Information... 1 Preferred Drug List... 2 Pharmacies... 3 Prescriptions... 4 Generic and Preferred Drugs... 5 Express Scripts Website and Mobile App... 5 Specialty Medicines... 5 Prior
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationPayment Example 2
Clinical Trial Agreements - A Moderated Discussion Health Care Compliance Association Research Compliance Conference June 3, 2015 EXAMPLES FOR DISCUSSION 1. PERSONNEL EXAMPLES Personnel Example 1 Institution
More informationChapter 8 Section 9.1
Other Services Chapter 8 Section 9.1 Issue Date: August 2002 Authority: 32 CFR 199.2(b), 32 CFR 199.4(b)(2)(vi), (b)(3)(iii), (b)(5)(v), (d)(3)(vi), (e)(11)(i), 32 CFR 199.5(d)(12); 32 CFR 199.17, and
More informationCLINICAL STUDY AGREEMENT
CLINICAL STUDY AGREEMENT This CLINICAL STUDY AGREEMENT ( Agreement ) is made effective as of the [number] day of [month], [year] (the Effective Date ), and is by and among Recitals (1) ASTRAZENECA [PHARMACEUTICALS]
More informationClinical Studies in H2020 Proposals
Clinical Studies in H2020 Proposals V 4.0 - March 2015 Mark Goldammer Mila Bas Sanchez Cornelius Schmaltz Directorate Health Research & Innovation European Commission Financial and Contractual Aspects
More informationCelgene Patient Support Learn about financial help for IDHIFA
Celgene Patient Support Learn about financial help for IDHIFA A Celgene Patient Support Specialist can help you and your loved ones understand the programs and services available to you. CELGENE PATIENT
More informationCalculating Accurate Metrics for the Actuarial Cost Model. Introduction. William Bednar, FSA, FCA, MAAA
Calculating Accurate Metrics for the Actuarial Cost Model William Bednar, FSA, FCA, MAAA Introduction Calculating metrics for an actuarial model sounds simple enough (just sum up the data!), but if proper
More informationSTATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Senator NIA H. GILL District (Essex and Passaic) SYNOPSIS Regulates pharmacy benefits management companies. CURRENT
More informationTip Sheet 25: Provisions in Contracts and Funding Agreements
Tip Sheet 25: Provisions in Contracts and Funding Agreements Related Accreditation Standard: I-8, Elements I.8.A., I.8.B., I.8.C., I.8.D., and I.8.E. AAHRPP Standard I-8 deals with five provisions for
More informationLEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements
LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP 2/14 Contents 1 Introduction... 3 2 Purpose... 3 3 Terminology and Definitions...
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationDISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY
DISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY 1. ASTELLAS S COMMITMENT 1.1 Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations ( EFPIA ). The
More informationParticipant Compensation
Lauren Hoctor, ORCRA/IRB, CCHMC Melinda Muenich, Clinical Trials Office, CCHMC, UC Health Participant Compensation Ethics, Taxes, and Common Practices Theoretical Models Free Market Wage Payment Reimbursement
More informationParticipant s Guide to t azur Group Medical Plan
Participant s Guide to t azur Group Medical Plan Introduction t azur Company b.s.c. (c), in partnership with your employer is providing you with a comprehensive healthcare plan, and we welcome you as
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationPamela Richtmyer MGH Research Compliance
Pamela Richtmyer MGH Research Compliance 1 ICH E6 Financial References Remuneration and Reimbursement Research Billing Best Practices 2 ICH Guideline for Good Clinical Practice: Consolidated Guidance (E6)
More informationImpacts: CLINICAL RESEARCH Last Revised: 02/10/2012 Subject: CLINICAL STUDY BUDGET FACILITATION & INITIATION POLICY
POLICY AND PROCEDURE MANUAL Pennington Biomedical POLICY NO. 301.00 Origin Date: 12/01/2008 Impacts: CLINICAL RESEARCH Last Revised: 02/10/2012 Subject: CLINICAL STUDY BUDGET FACILITATION & INITIATION
More informationLEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements
LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP 2/14 Contents 1 Introduction... 3 2 Purpose... 3 3 Terminology and Definitions...
More informationBuilding Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements
Building Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements Kelly Willenberg, DBA, RN, CHRC, CHC, CCRP Kelly Willenberg & Associates Wendy S. Portier, MSN,
More informationDOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2017 New Methodological Note
Document Title Methodological Note EFPIA Disclosure of Transfers of Value to Healthcare Professionals and Organisations ( Methodological Note on Disclosure ) Document Version 01 Effective Date 30JUN2017
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationBudgeting a Clinical Trial
Budgeting a Clinical Trial ROBIN J. DE PAGTER O P E R A T I O N S M A N A G E R O F F I C E O F S P O N S O R E D P R O J E C T S A D M I N I S T R A T I O N M A Y O C L I N I C d e p a g t e r. r o b
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More informationChapter 8 Section 9.1
Other Services Chapter 8 Section 9.1 Issue Date: August 2002 Authority: 32 CFR 199.2(b), 32 CFR 199.4(b)(2)(vi), (b)(3)(iii), (b)(5)(v), (d)(3)(vi), (e)(11)(i), 32 CFR 199.5(d)(12); 32 CFR 199.17, and
More informationGilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
More informationHealth Plans Dashboard
Health Plans Dashboard Q2 2015 Dashboard Summary Report A review of Inpatient, Outpatient and RX trends January 14, 2016 Prepared by HSS and Aon Hewitt Introduction This report completes the first phase
More informationCOLUMBIA UNIVERSITY MEDICAL CENTER INSTITUTIONAL REVIEW BOARD (IRB)
COLUMBIA UNIVERSITY MEDICAL CENTER INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES TO COMPLY WITH PRIVACY LAWS THAT AFFECT USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION FOR RESEARCH PURPOSES Procedures
More informationIRB MOU Procedures April 2018
Procedures to Implement the Reliance Memorandum of Understanding Among the University of California Campuses, UC Division of Agriculture and Natural Resources, and Lawrence Berkeley National Laboratory
More informationMedicaid Prescribed Drug Program. Spending Control Initiatives
Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, December 31, Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations and Spending
More informationEFPIA Transparency / LIF public reporting of transfers of value. Sobi Methodology Note Transfers of Value (reported 2017) Sweden
EFPIA Transparency / LIF public reporting of transfers of value Sobi Methodology Note 2016 Transfers of Value (reported 2017) Sweden 1 1. Background A new disclosure code was approved by European Federation
More informationTemplate for essential information to be provided for proposals including clinical trials / studies / investigations. Version 1.
Template for essential information to be provided for proposals including clinical trials / studies / investigations Version 1.1 1 February 2015 IMI2/INT/2015-00354 History of changes Version Date Change
More informationCost Reporting Principles April 4, 2007
Reimbursement Primer for Compliance, Ethics and Legal Officers: Everything You Have Always Wanted to Know About Reimbursement but Were Afraid to Ask. Cost Reporting Principles April 4, 2007 Douglas J.
More informationHealthcare. insurance. Helping people live healthier lives
Healthcare insurance Helping people live healthier lives You Deserve the Best Care Life uncertainties are inevitable. Your employees and their dependents are bound to face health issues at some time or
More information(AMA Council on Ethical and Judicial Affairs, Code of Medical Ethics, 7.05 Retention of Medical Records, ed.)
RECORD RETENTION AND DESTRUCTION FOR WYOMING ENTITIES By Kim C. Stanger, Melissa Y. Lou, and Chris D. Mack (rev d 8/21/18) Record. Ideally, healthcare providers should retain medical and other business
More informationAetna. CCHCA Physician Handbook (7 th Edition)
Part II Section A Aetna Introduction 1 Verifying Aetna Member Eligibility and Benefits 1 Aetna Sample Member ID Card 2 Aetna Prescription Drug Program 3 Pharmacy Benefit 4 Prior Authorization for Medications
More informationPhysician Office Solutions
Physician Office Solutions In the ever-changing world of healthcare, you can rely on us to help you improve your practice to face the challenges to come. Commitment That Extends Far Beyond Products We
More informationDOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2016 New Methodological Note
Document Title Methodological Note EFPIA Disclosure of Transfers of Value to Healthcare Professionals and Organisations in Poland ( Methodological Note on Disclosure ) Document Version 01 Effective Date
More informationMethodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office
Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP
More informationGet a 1-month supply of ENTRESTO at no cost to you *
Get a 1-month supply of ENTRESTO at no cost to you * FREE TRIAL OFFER * For all patients A program designed to guide you through treatment *Limitations apply. This voucher is good for a 30-day (maximum
More information*This document is searchable.
CCHP Prior Authorization List and Toll Free Phone Number 877-227-1142 Fax Number 414-266-4726 www. Childrenschp.com(childrenscommunityhealthplan.org) Utilization Provider Portal: provider.childrenscommunityhealthplan.org
More informationFrequently Asked Questions (FAQs) About the LIPITOR Savings Program*
Frequently Asked Questions (FAQs) About the LIPITOR Savings Program* *Terms and conditions apply. Please see page 9 for details. You may pay less by receiving the generic. Below are some FAQs about the
More informationMedicare Transition POLICY AND PROCEDURES
Medicare Transition POLICY AND PROCEDURES POLICY The Plan will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug Benefit Manual
More informationSAN FRANCISCO INTERNATIONAL AIRPORT SFO MEDICAL CLINIC RFP CONTRACT NO PRE-PROPOSAL CONFERENCE AUGUST 23, 2017
SAN FRANCISCO INTERNATIONAL AIRPORT SFO MEDICAL CLINIC RFP CONTRACT NO. 50118.01 PRE-PROPOSAL CONFERENCE AUGUST 23, 2017 1 AGENDA Introduction (Gerardo Fries B&F) Sign-Up Sheet / Participants Names & Organizations
More informationC o s t R e p o r t i n g : M e d i c a r e C o s t R e p o r t M o r e t h a n j u s t C o m p l i a n c e J u l y 1 8,
Cost Reporting 201: M edicare Cost Report More than just Compliance July 18, 2016 Wipfli LLP Wipfli LLP Agenda What will be covered today: Uses of information included in the Medicare Cost Report for a
More informationInside: Critical information about your company s prescription drug benefit.
Inside: Critical information about your company s prescription drug benefit. Questions Company Benefits Managers Must Ask Their PBM It pays to make an informed decision harmacy Benefit Managers, often
More informationMethodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code
Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Date Published: 31 May 2017 Index Annex 1: The disclosure in accordance with the Schedule 2 Template Annex
More informationFor Yale Faculty, Staff, and Students only
For Yale Faculty, Staff, and Students only Budget Book Fiscal Year 2017 Cover photo: Brandon Boyer YC 15 Analyst, Office of Financial Planning & Analysis, Yale University FY17 Operating and Capital Budget
More informationThe Merck Access Program ENROLLMENT FORM
The Merck Access Program ENROLLMENT FORM P: 877-709-4455 F: 800-977-1957 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM AND FAX IT TO 800-977-1957.
More informationPay as little as a $10 co-pay a month for ENTRESTO *
Pay as little as a $10 co-pay a month for ENTRESTO * $10 CO-PAY CARD * For eligible commercially insured patients A program designed to guide you through treatment *Limitations apply. This offer is not
More informationClinical Research Organisation Model Clinical Trial Agreement (CRO-mCTA)
Model Clinical Trial Agreement (mcta) and Clinical Research Organisation Model Clinical Trial Agreement (CRO-mCTA) Guidance February 2018 Model Clinical Trial Agreement and Clinical Research Organisation
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More information2019 Transition Policy and Procedure
2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process
More informationMethodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3
Date Published: 15 th March 2017 Version: 20 (December 4, 2015) Index Methodology for Compliance with the ABPI Disclosure Code Introduction Page 1 General Comments Page 2 Indirect Transfers of Value Page
More informationPharmaceutical Management Commercial Plans
Pharmaceutical Management Commercial Plans 2015 Toll Free Contact Number: (888) 327-0671 Medical Management: (810) 733-9711 Visit our website at: MclarenHealthPlan.org Introduction Pharmaceutical Management
More informationHEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE
HEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE Model development was made possible by the generous support of the American people through the United States Agency for International Development (USAID).
More informationAll Indiana Health Coverage Programs Physicians, Podiatrists, Dentists, Hospitals, Clinics, Mental Health Providers, and Pharmacies
Indiana Health Coverage Programs P R O V I D E R B U L L E T I N BT200132 AUGUST 10, 2001 To: All Indiana Health Coverage Programs Physicians, Podiatrists, Dentists, Hospitals, Clinics, Mental Health Providers,
More informationInspiration Health by HealthEast MN % City of Minneapolis Coverage Period: Beginning on or after 1/1/2017 Summary of Benefits and Coverage:
This is only a summary: If you want more detail about your coverage and costs, you can get the complete terms in the policy or plan document at www.medica.com or by calling 1-855-469-6334. Important Questions
More information1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.
1 INSURANCE SECTION : This section contains information about the cardholder and their plan identification. 1 ID of Cardholder Required. Enter the recipient s 13 digit Medicaid ID. 2 Group ID Not Required.
More informationPrescription Drug Coverage
The Company s medical plans automatically include coverage for prescription drugs which is administered by Envision Pharmaceutical Services, Inc. (Envision Rx) for prescriptions filled at retail pharmacies
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca UK Limited Registered in England No 3674842 Registered Office, 2 Kingdom Street, London,
More informationGlossary of Terms. Adjudication: The way a health plan decides how much it will pay for certain expenses.
Page 1 Glossary of Terms Adjudication: The way a health plan decides how much it will pay for certain expenses. Affordable Care Act (ACA): The comprehensive health care reform law enacted in March 2010.
More informationPROVIDER MANUAL. In the Colorado Access Provider Manual, you will find information about:
In the Colorado Access Provider Manual, you will find information about: Section 1. Colorado Access General Information Section 2. Colorado Access Policies Section 3. Quality Management Section 4. Provider
More informationThe Health Plan has processes in place that explain how members, pharmacists, and physicians:
Introduction Overview The Health Plan shall promote optimal therapeutic use of pharmaceuticals by encouraging the use of cost effective generic and/or brand drugs in certain therapeutic classes. The Health
More informationGuide to Identifying and Measuring Private Business Use in Tax-Exempt Bond-Financed Facilities
Guide to Identifying and Measuring Private Business Use in Tax-Exempt Bond-Financed Facilities I. Introduction The University of Washington (the University ) frequently finances facilities in whole or
More informationAny healthcare professional and healthcare organization whose primary practice, principal professional address or place of incorporation
METHODOLOGICAL NOTE on the EFPIA disclosure of transfers of value to healthcare professionals and organizations Country: Russia Last Update: 25.04.2018 Version: 02; this document replaces previous drafts
More information